Evidence mapPaperPMID 40994749Full record

ArticleFrontiers in public health2025

A comprehensive study of hip dislocation: global health burden from 1990 to 2021 and its predictions to 2030.

Xu Zheng, Cheng Chen, Youguang Zhao, Jiantao Jiang, You Wang

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xu Zheng *Department of Bone and Joint Surgery, Department of Orthopedics, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Cheng Chen *Department of Orthopedics, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Youguang ZhaoDepartment of Orthopedics, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Jiantao JiangDepartment of Orthopedics, Shaoxing Shangyu Traditional Chinese Medicine Hospital, Shaoxing, China.
You WangDepartment of Bone and Joint Surgery, Department of Orthopedics, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Hip dislocation is a critical clinical emergency that demands immediate intervention to prevent complications such as avascular necrosis, nerve damage, and long-term joint dysfunction. As population demographics evolve-with aging populations and increasing urbanization-and injury patterns shift due to factors such as road traffic accidents, sports-related injuries, and occupational hazards, the need to update our understanding of the epidemiology of hip dislocation becomes ever more pressing. These changes highlight the importance of identifying high-risk groups and tailoring preventive and therapeutic strategies accordingly. This study leverages comprehensive data from the Global Burden of Disease (GBD) 2021 to analyze the latest trends, disease burden, and population-specific patterns of hip dislocation. This analysis aims to produce evidence-based insights that inform clinical practice, guide public health policies, and promote efficient resource allocation. The findings will also help predict future trends, enabling proactive measures to mitigate the impact of hip dislocation on global health. Methods: Data from the GBD 2021 was utilized to calculate the estimated annual percentage change in hip dislocation metrics. A comprehensive analysis of population patterns was conducted, focusing specifically on region, age and gender distributions. Key measures included crude and age-standardized incidence rates, crude and age-standardized Years Lived with Disability (YLDs) rates, and absolute case numbers and corresponding 95% uncertainty intervals (UIs). The estimated annual percentage change (EAPC) and corresponding 95% confidence intervals (CIs) were calculated, with positive EAPC values indicating an increasing trend and negative values indicating a decreasing trend. Socio-Demographic Index (SDI) was cross-analyzed with other study indicators to examine potential correlations. Bayesian Age-Period-Cohort models, implemented through the BAPC R package, were used to project changes in the disease burden of hip dislocation by 2030. Results: From 1990 to 2021, the incidence rate and YLDs rate of hip dislocation decreased, while the number of cases and YLDs number increased. The disease burden is relatively high among the youth (15-24) and the older population (50+). In SDI-stratified analyses, incidence gaps narrowed across all quintiles, yet low-SDI regions still bore a comparatively higher residual disability burden by 2020. Males have consistently faced a heavier burden than females. High-energy trauma, particularly falls, warrants special attention in the older population. The total number of hip dislocation cases will increase, while the corresponding rate declines. Men will still bear a substantial disease burden of hip dislocation by 2030. Conclusion: The disease burden of hip dislocation remains a significant public health challenge. Data-driven analysis is pivotal for guiding clinical practice, shaping public health policies, and ensuring optimal allocation of healthcare resources. Strategic efforts are needed to address the persisting burden, particularly among high-risk demographic groups.

Indexed as

Global Burden of DiseaseGlobal HealthHip DislocationAdolescentAdultAgedAged, 80 and overChildDisability-Adjusted Life YearsFemaleHumansIncidenceMaleMiddle AgedYoung AdultepidemiologyGlobal Burden of Diseasehip dislocationincidenceYLDs

Identifiers

PMID40994749
PMCPMC12454331

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.